After stratifying patients based on a 2-fold reduction in serum CRP levels from the baseline and attainment of the reference range after 10–12 days of anti-TB therapy, it was found that 31.4% did not achieve the expected decrease (Group C). This evidence concerns the gene CRP and tuberculosis.